PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States.\', \'Antimicrobial Resistance Integrated Research Group, Singapore-MIT Alliance for Research and Technology, 1 CREATE Way, Singapore 138602, Singapore.\', \'Quanterix Corporation, Billerica, Massachusetts 01821, United States.\', \'Department of Biochemistry, Boston University School of Medicine, Boston, Massachusetts 02118, United States.\', \'National Emerging Infectious Diseases Laboratories (NEIDL), Boston, Massachusetts 02188, United States.\', \'Department of Chemistry, Tufts University, Medford, Massachusetts 02155, United States.\', \'3M Company, St. Paul, Minnesota 55133, United States.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1021/acsami.1c08174
?:doi
?:hasPublicationType
?:journal
  • ACS applied materials & interfaces
is ?:pmid of
?:pmid
?:pmid
  • 34379400
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.784
?:rankingScore_hIndex
  • 143
?:title
  • Developing a SARS-CoV-2 Antigen Test Using Engineered Affinity Proteins.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all